Taken together, our findings indicate that increased numbers of M2 TAMs in the tumor foci of EC patients increase IL-10 expression, which stimulates IFN-γ release from CD8+ T cells, leading to IDO1 expression by EC cells and the attenuation of tumor-infiltrating CD8+ T cell responses. This evidence concerns the gene CD8A and neoplasm.